Brandon Sim - 02 Feb 2026 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Signature
/s/ Kathy Diep, as Attorney-in-Fact
Issuer symbol
ASTH
Transactions as of
02 Feb 2026
Net transactions value
+$495,802
Form type
4
Filing time
03 Feb 2026, 21:37:01 UTC
Previous filing
07 Mar 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sim Brandon CEO and President C/O ASTRANA HEALTH, INC., 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA /s/ Kathy Diep, as Attorney-in-Fact 03 Feb 2026 0001813532

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASTH Common Stock Options Exercise $495,802 +21,334 +2.1% $23.24 1,045,329 02 Feb 2026 Direct F3, F4
holding ASTH Common Stock 258,824 02 Feb 2026 By Sim Family Irrevocable Trust 2021 F1
holding ASTH Common Stock 392,816 02 Feb 2026 By Brandon Sim 2020 Irrevocable Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASTH Stock Option (right to buy) Options Exercise $0 -21,334 -100% $0.000000 0 02 Feb 2026 Common Stock 21,334 $23.24 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held by the Sim Family Irrevocable Trust 2021. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F2 These securities are held by the Brandon Sim 2020 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F3 Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 29,919 shares, which will vest on June 27, 2026; and (ii) 51,309 shares, which will vest in three equal semi-annual installments, beginning March 31, 2026. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 75,433 restricted stock units, which will vest in five equal semi-annual installments beginning on April 2, 2026; and (ii) 127,437 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026.
F4 Includes 1,420 shares acquired under the Issuer's Employee Stock Purchase Plan.
F5 These stock options were fully vested and exercisable.